Financhill
Sell
44

LODE Quote, Financials, Valuation and Earnings

Last price:
$0.36
Seasonality move :
19.68%
Day range:
$0.30 - $0.34
52-week range:
$0.13 - $0.72
Dividend yield:
0%
P/E ratio:
2.48x
P/S ratio:
25.45x
P/B ratio:
1.04x
Volume:
4.9M
Avg. volume:
3.6M
1-year change:
-23.39%
Market cap:
$71M
Revenue:
$1.3M
EPS (TTM):
-$0.12
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $179.6K $201.7K $862.2K $178.2K $1.3M
Revenue Growth (YoY) 19.52% 12.29% 327.45% -79.34% 615.38%
 
Cost of Revenues $1.5M $51.9K $272.1K -- --
Gross Profit -$1.4M $149.8K $590.1K -- --
Gross Profit Margin -755.21% 74.27% 68.44% -- --
 
R&D Expenses -- -- $414.8K $7M $6.1M
Selling, General & Admin $3.3M $4.4M $5.5M $10.2M $12.6M
Other Inc / (Exp) $2.2M $20.1M -$24.8M -$25.1M $31.8M
Operating Expenses $3.8M $5.4M $7M $20.6M $21.2M
Operating Income -$5.2M -$5.2M -$6.4M -$20.4M -$19.9M
 
Net Interest Expenses $879.5K -- -- $1.3M $1.4M
EBT. Incl. Unusual Items -$3.8M $14.9M -$30.3M -$46.7M $10.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$5.7M -- --
Net Income to Company -$3.8M $14.9M -$24.6M -$46.7M $10.5M
 
Minority Interest in Earnings -- -- -- $789.5K -$1.4M
Net Income to Common Excl Extra Items -$3.8M $14.9M -$24.6M -$45.9M $9.2M
 
Basic EPS (Cont. Ops) -$0.20 $0.49 -$0.49 -$0.62 $0.09
Diluted EPS (Cont. Ops) -$0.20 $0.49 -$0.49 -$0.62 $0.09
Weighted Average Basic Share $19.5M $30.5M $50.4M $74.5M $105.1M
Weighted Average Diluted Share $19.5M $30.6M $50.4M $74.5M $105.2M
 
EBITDA -$1.1M $16.6M -$29.1M -$41.8M $14.7M
EBIT -$2.9M $15.4M -$30.2M -$45.1M $12.2M
 
Revenue (Reported) $179.6K $201.7K $862.2K $178.2K $1.3M
Operating Income (Reported) -$5.2M -$5.2M -$6.4M -$20.4M -$19.9M
Operating Income (Adjusted) -$2.9M $15.4M -$30.2M -$45.1M $12.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $49.4K $362.7K $39.9K $760.7K $556.4K
Revenue Growth (YoY) 2.22% 633.87% -89.01% 1808.96% -26.86%
 
Cost of Revenues $9.8K -- -- -- --
Gross Profit $39.6K -- -- -- --
Gross Profit Margin 80.12% -- -- -- --
 
R&D Expenses -- $164.3K $1.3M $1.4M $1.4M
Selling, General & Admin $846K $1.6M $1.9M $3.1M $3.2M
Other Inc / (Exp) $19.1M -$8M -$1M $18.4M -$9.8M
Operating Expenses $1.8M $2.1M $4M $5.2M $5.2M
Operating Income -$1.7M -$1.7M -$4M -$4.5M -$4.6M
 
Net Interest Expenses $23.4K -- $316.9K $247.7K $616K
EBT. Incl. Unusual Items $17.3M -$9.5M -$5.3M $13.7M -$15M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $17.3M -$9.5M -$5.3M $13.7M -$15M
 
Minority Interest in Earnings -- -- $188.8K -$1.4M $26.6K
Net Income to Common Excl Extra Items $17.3M -$9.5M -$5.1M $12.4M -$15M
 
Basic EPS (Cont. Ops) $0.54 -$0.17 -$0.07 $0.11 -$0.08
Diluted EPS (Cont. Ops) $0.54 -$0.17 -$0.07 $0.11 -$0.08
Weighted Average Basic Share $32.1M $54.6M $76.5M $109.1M $187.9M
Weighted Average Diluted Share $32.1M $54.6M $76.5M $110.4M $187.9M
 
EBITDA $18.3M -$9.1M -$4.2M $14.7M -$13.7M
EBIT $17.5M -$9.5M -$5M $14.1M -$14.3M
 
Revenue (Reported) $49.4K $362.7K $39.9K $760.7K $556.4K
Operating Income (Reported) -$1.7M -$1.7M -$4M -$4.5M -$4.6M
Operating Income (Adjusted) $17.5M -$9.5M -$5M $14.1M -$14.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $195.7K $521.3K $543.7K $857.5K $1.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $387.5K -- -- -- --
Gross Profit -$191.8K -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $5.4M $6.3M $6.6M
Selling, General & Admin $3.6M $4.6M $9.6M $13.5M $12.1M
Other Inc / (Exp) $23.2M -$7.1M -$30.8M $5.4M -$1.1M
Operating Expenses $4.9M $5M $17.9M $22.7M $21M
Operating Income -$5.1M -$4.5M -$17.6M -$21.8M -$19.1M
 
Net Interest Expenses $108.6K -- $245.8K $1.8M $2.3M
EBT. Incl. Unusual Items $18.1M -$11M -$48.7M -$18.2M -$22.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $18.1M -$11M -$42.9M -$18.2M -$22.6M
 
Minority Interest in Earnings -- -- $681K -$1.2M $25K
Net Income to Common Excl Extra Items $18.1M -$11M -$42.2M -$19.4M -$22.6M
 
Basic EPS (Cont. Ops) $0.58 -$0.24 -$0.68 -$0.26 -$0.12
Diluted EPS (Cont. Ops) $0.58 -$0.24 -$0.68 -$0.26 -$0.12
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $19.8M -$5.4M -$44.8M -$13.3M -$17.6M
EBIT $18.4M -$6.2M -$47.7M -$16.2M -$20M
 
Revenue (Reported) $195.7K $521.3K $543.7K $857.5K $1.9M
Operating Income (Reported) -$5.1M -$4.5M -$17.6M -$21.8M -$19.1M
Operating Income (Adjusted) $18.4M -$6.2M -$47.7M -$16.2M -$20M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $146.2K $465.8K $147.4K $826.8K $1.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $212K -- -- -- --
Gross Profit -$65.7K -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- $164.3K $5.1M $4.4M $4.9M
Selling, General & Admin $2.6M $2.8M $6.8M $10M $9.5M
Other Inc / (Exp) $22.1M -$5.1M -$11.1M $19.3M -$13.7M
Operating Expenses $3.7M $3.5M $14.4M $16.5M $16.3M
Operating Income -$3.7M -$3M -$14.2M -$15.6M -$14.8M
 
Net Interest Expenses $66.8K -- $627.4K $1.1M $2.1M
EBT. Incl. Unusual Items $18.3M -$7.6M -$26M $2.6M -$30.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company $18.3M -$7.6M -$26M $2.6M -$30.6M
 
Minority Interest in Earnings -- -- $681K -$1.3M $62.2K
Net Income to Common Excl Extra Items $18.3M -$7.6M -$25.3M $1.2M -$30.5M
 
Basic EPS (Cont. Ops) $0.58 -$0.10 -$0.36 -- -$0.20
Diluted EPS (Cont. Ops) $0.58 -$0.10 -$0.36 -- -$0.20
Weighted Average Basic Share $87.6M $135.5M $212.5M $305.2M $448.2M
Weighted Average Diluted Share $87.7M $135.5M $212.5M $306.4M $448.2M
 
EBITDA $19.7M -$2.2M -$22.5M $5.9M -$26.4M
EBIT $18.6M -$2.9M -$25M $3.9M -$28.3M
 
Revenue (Reported) $146.2K $465.8K $147.4K $826.8K $1.4M
Operating Income (Reported) -$3.7M -$3M -$14.2M -$15.6M -$14.8M
Operating Income (Adjusted) $18.6M -$2.9M -$25M $3.9M -$28.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1M $2.4M $5.9M $2.5M $3.8M
Short Term Investments -- $4M $925.8K -- $18.9M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $1.6M $145.6K $347.5K $809.6K $14K
Other Current Assets $199.9K $196K $1.3M $761.4K $470.6K
Total Current Assets $13.3M $20.8M $13.8M $30.8M $23.2M
 
Property Plant And Equipment $5.7M $6.6M $21.7M $15.5M $16.2M
Long-Term Investments $9.4M $3.3M $25.9M $18.8M $31.3M
Goodwill -- -- $12.8M -- --
Other Intangibles -- -- $23.2M $17.7M $15.9M
Other Long-Term Assets $3.2M $2.9M $3M $2.9M $3.3M
Total Assets $39.6M $43.1M $127M $100.1M $106.5M
 
Accounts Payable $922.6K $313.8K $633.2K $714.1K $1.3M
Accrued Expenses $1.9M $535K $939.4K $1.7M $2.3M
Current Portion Of Long-Term Debt $328.1K $3.6M -- $1.8M $4.5M
Current Portion Of Capital Lease Obligations -- -- $13M $409.1K $838.7K
Other Current Liabilities $1.3M $419.3K $9.3M $27M $5.8M
Total Current Liabilities $4.4M $4.8M $23.9M $31.6M $14.8M
 
Long-Term Debt $5.1M -- $4.5M $6.1M $5.4M
Capital Leases -- -- -- -- --
Total Liabilities $16.1M $11.3M $34M $43.7M $28.2M
 
Common Stock $18.1K $22.9K $47.1K $60.7K $78.4K
Other Common Equity Adj -- -- -- -- --
Common Equity $23.2M $31.8M $89.6M $53.6M $78.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $269.5K -- $3.4M $2.8M --
Total Equity $23.5M $31.8M $93M $56.4M $78.3M
 
Total Liabilities and Equity $39.6M $43.1M $127M $100.1M $106.5M
Cash and Short Terms $1M $6.4M $6.8M $2.5M $22.7M
Total Debt $5.4M $3.6M $4.5M $7.9M $9.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.7M $2.9M $1.2M $3.4M $1.4M
Short Term Investments $9.7M $1.1M $2K $18.9M $18.9M
Accounts Receivable, Net -- $371.8K -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $1.3M $326.3K $189K $370.1K --
Other Current Assets $344.1K $219.9K $1.8M $1.5M $799.8K
Total Current Assets $26M $35.5M $8.1M $30.7M $29.9M
 
Property Plant And Equipment $13.3M $12.9M $35.8M $16.2M $19.1M
Long-Term Investments $937.5K $27.1M $20.5M $12.9M $31.4M
Goodwill -- $17.7M $12.8M -- --
Other Intangibles -- $7.5M $21.7M $16.2M $5.9M
Other Long-Term Assets $3.1M $2.7M $3M $3.4M $3.6M
Total Assets $48.2M $107.4M $116.5M $94.6M $103.7M
 
Accounts Payable $736.8K $1.3M $401.5K $557.1K $2.5M
Accrued Expenses $449.9K $419.6K $638.5K $997K $1.3M
Current Portion Of Long-Term Debt -- -- -- -- $626K
Current Portion Of Capital Lease Obligations -- -- $14.9M $847.1K $515.1K
Other Current Liabilities $498.1K $2.4M $16.4M $7.9M $1.3M
Total Current Liabilities $6.4M $4.2M $32.3M $11.7M $12.2M
 
Long-Term Debt $75.1K -- $3.9M $5.8M $10.6M
Capital Leases -- -- -- -- --
Total Liabilities $13M $9.6M $43.1M $24.8M $35.6M
 
Common Stock $22.9K $42.5K $54.6K $77.9K $137.7K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $3.2M $3.9M $110.4K
Total Equity $35.2M $97.8M $73.4M $69.9M $68.1M
 
Total Liabilities and Equity $48.2M $107.4M $116.5M $94.6M $103.7M
Cash and Short Terms $11.4M $4M $1.2M $22.4M $20.3M
Total Debt $4.8M -- $3.9M $5.8M $11.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$3.8M $14.9M -$24.6M -$46.7M $10.5M
Depreciation & Amoritzation -- $1.2M $1.1M $2.8M $2.4M
Stock-Based Compensation -- $204.3K $464K $482K -$2.3K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2.3M -$3.8M -$7.5M -$12.1M -$13.6M
 
Capital Expenditures $2.4M $130.8K $78.5K $3.2M $200K
Cash Acquisitions $4.8M -$1.6M -$12.8M -$750K -$12M
Cash From Investing $2.6M $3.2M -$16.1M -$3.7M $3.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $5.5M $4.6M $5M $5M
Long-Term Debt Repaid -$4.7M -$7.6M -$3.6M -$3.8M -$301.5K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$270.8K -$130.1K -$1.1M $217.8K -$320K
Cash From Financing $192.1K $2M $27.1M $12.4M $11.3M
 
Beginning Cash (CF) $488.7K $1M $2.4M $5.9M $2.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $527.2K $1.4M $3.5M -$3.4M $1.3M
Ending Cash (CF) $1M $2.4M $5.9M $2.5M $3.8M
 
Levered Free Cash Flow -$4.7M -$3.9M -$7.6M -$15.3M -$13.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $17.3M -$9.5M -$5.3M $13.7M -$15M
Depreciation & Amoritzation $1.1M $394.6K $657.2K $643.4K $548.1K
Stock-Based Compensation -- $127.7K $89.9K -$240.2K $43.2K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2M -$1.7M -$4M -$4.5M -$3.8M
 
Capital Expenditures $4K -- $355.2K $12.7M $439K
Cash Acquisitions -$1.4M -$1.4M -$1.5M $12M --
Cash From Investing -$566.6K -$4.1M -$415K $2.8M -$2.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.2M -- -- -- $6M
Long-Term Debt Repaid -$4.8M -$56.3K -$1.4M -$25.1K -$675.1K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$80K -$1.5K -$2.5K -$70.4K -$90K
Cash From Financing $3.3M $3.9M $1.3M $3.6M $7.2M
 
Beginning Cash (CF) $968.2K $5.3M $4.3M $1.6M $114.3K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $709K -$1.8M -$3.2M $1.9M $1.2M
Ending Cash (CF) $1.7M $3.4M $1.2M $3.4M $1.4M
 
Levered Free Cash Flow -$2M -$1.7M -$4.4M -$17.2M -$4.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $18.1M -$11M -$42.9M -$18.2M -$22.6M
Depreciation & Amoritzation -- $749.5K $2.5M $2.7M $2.3M
Stock-Based Compensation $204.2K $329.7K $446.2K $102.5K $207.8K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2.4M -$6.3M -$14.2M -$11.5M -$12.1M
 
Capital Expenditures $816.4K $163.5K $1.7M $15M -$12.4M
Cash Acquisitions $4M -$3.6M -$11.6M $1.5M -$12M
Cash From Investing $839.7K -$7.8M -$4.9M $2.6M -$9.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $13M
Long-Term Debt Repaid -$6.6M -$6.1M -$1.4M -$2.7M -$849.6K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$129.4K -$1.1M $232.8K -$343K -$222.1K
Cash From Financing $3M $15.9M $16.8M $11.2M $19.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.4M $1.7M -$2.3M $2.3M -$2.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$3.3M -$6.5M -$16M -$26.6M $351.4K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $18.3M -$7.6M -$26M $2.6M -$30.6M
Depreciation & Amoritzation $1.1M $624.2K $2.1M $2M $1.8M
Stock-Based Compensation $204.3K $329.7K $311.9K -$67.6K $142.5K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$2.4M -$5M -$11.7M -$11.2M -$9.6M
 
Capital Expenditures $15K $47.8K $1.7M $13.5M $904.9K
Cash Acquisitions -$1.4M -$3.4M -$2.2M -- --
Cash From Investing -$141.9K -$11.1M $101.2K $6.5M -$6.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4.2M -- -- -- $8M
Long-Term Debt Repaid -$5.1M -$3.6M -$1.4M -$377.1K -$925.2K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$130.1K -$1.1M $232.8K -$328K -$230.1K
Cash From Financing $3.2M $17.1M $6.9M $5.6M $14.1M
 
Beginning Cash (CF) $3M $18M $12.5M $12.2M $4.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $661.4K $985.9K -$4.8M $918.3K -$2.4M
Ending Cash (CF) $3.7M $19M $7.8M $13.1M $1.9M
 
Levered Free Cash Flow -$2.4M -$5M -$13.4M -$24.7M -$10.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 0.51% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.38% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock